Legal & General Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.18M Buy
166,181
+18,074
+12% +$999K ﹤0.01% 1239
2025
Q1
$7.16M Sell
148,107
-4,455
-3% -$215K ﹤0.01% 1326
2024
Q4
$5.89M Sell
152,562
-444
-0.3% -$17.1K ﹤0.01% 1497
2024
Q3
$6.89M Buy
153,006
+99,720
+187% +$4.49M ﹤0.01% 1404
2024
Q2
$1.85M Buy
53,286
+2,600
+5% +$90.1K ﹤0.01% 1977
2024
Q1
$1.47M Buy
50,686
+5,397
+12% +$156K ﹤0.01% 2051
2023
Q4
$1.04M Buy
45,289
+524
+1% +$12K ﹤0.01% 2193
2023
Q3
$747K Buy
44,765
+265
+0.6% +$4.42K ﹤0.01% 2286
2023
Q2
$1.23M Buy
44,500
+25,364
+133% +$701K ﹤0.01% 2129
2023
Q1
$440K Buy
19,136
+4,728
+33% +$109K ﹤0.01% 2355
2022
Q4
$157K Buy
14,408
+1,118
+8% +$12.2K ﹤0.01% 2697
2022
Q3
$112K Sell
13,290
-4,836
-27% -$40.8K ﹤0.01% 2785
2022
Q2
$143K Sell
18,126
-3,468
-16% -$27.4K ﹤0.01% 2753
2022
Q1
$511K Buy
21,594
+330
+2% +$7.81K ﹤0.01% 2391
2021
Q4
$727K Buy
21,264
+632
+3% +$21.6K ﹤0.01% 2313
2021
Q3
$365K Buy
20,632
+8,071
+64% +$143K ﹤0.01% 2509
2021
Q2
$563K Buy
12,561
+2,016
+19% +$90.4K ﹤0.01% 2317
2021
Q1
$273K Buy
10,545
+233
+2% +$6.03K ﹤0.01% 2397
2020
Q4
$208K Buy
10,312
+6,696
+185% +$135K ﹤0.01% 2412
2020
Q3
$71K Sell
3,616
-106
-3% -$2.08K ﹤0.01% 2582
2020
Q2
$66K Buy
3,722
+1,033
+38% +$18.3K ﹤0.01% 2644
2020
Q1
$19K Sell
2,689
-822
-23% -$5.81K ﹤0.01% 2930
2019
Q4
$25K Buy
3,511
+426
+14% +$3.03K ﹤0.01% 3120
2019
Q3
$37K Buy
3,085
+555
+22% +$6.66K ﹤0.01% 2868
2019
Q2
$31K Buy
+2,530
New +$31K ﹤0.01% 3001
2018
Q2
Sell
-2,205
Closed -$19K 3378
2018
Q1
$19K Hold
2,205
﹤0.01% 3126
2017
Q4
$46K Buy
2,205
+487
+28% +$10.2K ﹤0.01% 2893
2017
Q3
$30K Buy
1,718
+691
+67% +$12.1K ﹤0.01% 3060
2017
Q2
$12K Hold
1,027
﹤0.01% 3297
2017
Q1
$13K Sell
1,027
-316
-24% -$4K ﹤0.01% 3161
2016
Q4
$30K Buy
+1,343
New +$30K ﹤0.01% 3028